Financials

  • Market Capitalization 78.85 M
  • Employee 33
  • Founded 2011
  • CEO N/A
  • Website www.elicio.com
  • Headquarter Delaware, United States
  • FIGI BBG00444GM02
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.09
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4059
GANX
Gain Therapeutics, Inc. - Common Stock
1.78 USD-3.78%-11.00%+2.30%-6.81%77.69 M USD
4066
CING
Cingulate Inc. - Common Stock
5.44 USD+0.74%-0.37%+20.89%-11.69%79.11 M USD
4087
NRXS
Neuraxis, Inc. Common Stock
5.98 USD-1.16%-3.70%-7.00%+10.13%75.10 M USD
4102
ANVS
Annovis Bio, Inc. Common Stock
1.73 USD-4.42%-2.81%+1.17%-25.11%73.71 M USD

Nouvelles